| Summary: | Charge heterogeneity is a critical quality attribute for mAb-based therapeutics. Its characterization involves the identification of charge variant species in the final formulation. Capillary zone electrophoresis (CZE) is a valuable tool to assess charge heterogeneity, but typically offers incomplete separation of the different charged isoforms. Cyclodextrin-mediated chiral CE is a well-established electromigration method. In this paper, we propose the use of cyclodextrins as modulators for CZE based separation of mAb charge variants. Uncoated fused silica capillaries have been used for examining charge heterogeneity in biosimilars of Rituximab and Trastuzumab in presence of different cyclodextrins. Both the negatively charged CMβCD and uncharged HPβCD have been explored. The effect of cyclodextrin concentration has been found to impact the extent of modulation of resolution of charge variants. Addition of 10 mM CMβCD not only improved resolution but also resulted in separation of two additional basic and one additional acidic species for Rituximab. Similarly, besides improvement in the resolution of separation, one additional basic variant was observed with 2.5 mM CMβCD with another sample, Trastuzumab. The paper demonstrates that the effect of CMβCD is mAb specific. No improvement in resolution was, however, observed with HPβCD, suggesting the selective nature of cyclodextrins for mAb variants.
|
|---|